CALR and lymphoma: The absence of anti-SSA or anti-SSB antibodies in one-third of PSS patients and the inadequacy of markers predicting lymphoma highlight the necessity of investigating new autoantibodies that can be used in diagnosing PSS and predicting lymphoma development.